Skip to main content
logo
NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.960
+0.060 (3.16%)
At close: Aug 14, 2026, 4:00 PM EDT
1.970
+0.010 (0.49%)
After-hours: Aug 14, 2026, 7:55 PM EDT

NovaBridge Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-88.34-22.23-207.73-371.05-367.02
Depreciation & Amortization
0.860.981.061.424.84
Other Amortization
---2.250.12
Loss (Gain) From Sale of Assets
0.02-0.01--0.030.05
Asset Writedown & Restructuring Costs
42.071.2523.04--
Loss (Gain) From Sale of Investments
1.75--0.22-1.9-4.78
Loss (Gain) on Equity Investments
-1.0411.464.7157.91
Stock-Based Compensation
5.97-1.9510.2413.1595.8
Other Operating Activities
--28.93126.63224.78-2.21
Change in Accounts Receivable
---1.5511.18
Change in Inventory
-----4.29
Change in Unearned Revenue
----34.08
Change in Other Net Operating Assets
17.07-2.81-37.1215.5521.13
Operating Cash Flow
-20.6-106.63-146.5-90.22-153.18
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.05-0.16-2.09-4.71
Sale of Property, Plant & Equipment
0.050.06---
Investment in Securities
104.93-136.03-15-3.09-109.76
Investing Cash Flow
104.97-136.02-15.16-5.18-114.47

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
61.91-0.416.92115.31
Repurchase of Common Stock
--0.34-8.64-3.01-
Other Financing Activities
-4.19----21.82
Financing Cash Flow
57.73-0.34-8.243.9193.49

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.280.575.214.2-20.27
Net Cash Flow
142.37-242.4-164.7-77.3-194.43

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-20.6-106.68-146.66-92.32-157.89
Free Cash Flow Growth
-----
Free Cash Flow Margin
---23206.33%--1139.46%
Free Cash Flow Per Share
-0.21-1.31-1.76-1.12-2.08
Levered Free Cash Flow
-37.11-68.15-58.8447.43-96.12
Unlevered Free Cash Flow
-37.11-68.15-58.8447.43-96.12

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---0.1-
Cash Income Tax Paid
----1.43
Change in Working Capital
17.07-2.81-37.1217.0962.1
SEC Filings: 10-K · 10-Q